Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1683307

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 December 2023 to Question 5383 on NHS: Standards, what steps her Department is taking to to ensure quality improvement across (a) NHS England, (b) Integrated Health and Care Boards and (c) NHS Hospital Trusts.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	10452
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>NHS Improving Patient Care Together is the single improvement approach to support all National Health Service organisations, systems, and providers at every level, including NHS England, to have the skills and techniques to deliver continuous improvement. Information and resources are available at the following link:</p><p> </p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.england.nhs.uk%2Fnhsimpact%2Fabout-nhs-impact%2F&amp;data=05%7C02%7CFrancesca.Day%40dhsc.gov.uk%7C679a326c09594acdc07e08dbfc005597%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638380850600125951%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=3fC5Kj0WuJz7kdclLWI9HRzV20VSjoxtP%2BMzeb3RHbk%3D&amp;reserved=0" target="_blank">https://www.england.nhs.uk/nhsimpact/about-nhs-impact/</a></p><p> </p><p>The performance of integrated care boards (ICBs) in the exercise of their functions is assessed, annually, by NHS England. The NHS Oversight Framework describes NHS England’s approach to the oversight of ICBs, and is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/nhs-oversight-framework/" target="_blank">https://www.england.nhs.uk/nhs-oversight-framework/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:17:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4124 label Biography information for Chi Onwurah

1683320

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce waiting times for treatments for (a) breast, (b) ovarian and (c) prostate cancer.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	10442
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>Reducing waiting times for treatments of all types of cancer is a priority for the Government, as is increasing early cancer diagnosis as this is a key contributor to reducing cancer health inequalities. We are expanding capacity through our community diagnostic centres (CDCs) supported by £2.3 billion of capital funding with 150 CDCs currently operational and having delivered over six million additional tests, checks and scans including vital cancer checks since January 2021.</p><p>The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer and will consider a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients, including those less survivable cancers.</p><p>NHS England has commissioned six cancer clinical audits which will provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments and help stimulate improvements in cancer treatments and outcomes for patients, including ovarian cancer, pancreatic cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. The Royal College of Surgeons began work on this audit in October 2022, and the first outcomes expected in September 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/01/2024 11:44:53 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3924 label Biography information for Yasmin Qureshi

1683384

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Internet
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to prevent the selling of prescription drugs online without requiring a prescription.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	10418
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulator in the United Kingdom for human medicines and is responsible for enforcing the Human Medicines Regulations 2012, which are available at the following link:</p><p><a href="https://www.legislation.gov.uk/uksi/2012/1916/contents/made" target="_blank">https://www.legislation.gov.uk/uksi/2012/1916/contents/made</a><br> <br> The MHRA has identified the illegal sale and supply of human medicines as a global challenge. This includes the sale of prescription drugs without a prescription from unregulated sources. Criminal gangs, often based overseas, advertise medicines through illicit websites resembling those of legitimate pharmacies, while others exploit online marketplaces or sell social media platforms.</p><p>The MHRA has a dedicated Criminal Enforcement Unit (CEU) that works with partners across the Government, policing to prevent and disrupt this illegal trade and to bring to justice those involved. The CEU monitors online channels for evidence of illegal activity and takes proportionate regulatory action. This includes using the full range of the Agency’s powers to investigate and prosecute offenders where necessary and appropriate. The unit also works to remove illegally trading websites and remove criminal profits from offenders. Through its #FakeMeds communications campaign the MHRA also provides quick and easy tools to help the public avoid buying illegally traded medicines when they shop online.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/01/2024 11:37:30 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1447 label Biography information for Andrew Rosindell

1683468

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of an action plan for the less survivable cancers.
tabling member constituency	Norwich North
tabling member printed	Chloe Smith
uin	10434
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>Cancer is being diagnosed at earlier stages, more often, with survival rates improving across almost all types of cancer with the National Health Service seeing and treating record numbers of cancer patients over the last two years.</p><p>The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients, including those less survivable cancers. We have already acted upon some of the areas that the 2020 Less Survivable Cancer Taskforce report requested, for example the introduction of targeted lung health checks, trials for cytosponge, and the roll out of non-specific symptom pathways. The report is available at the following link:</p><p><a href="https://lesssurvivablecancers.org.uk/our-asks/" target="_blank">https://lesssurvivablecancers.org.uk/our-asks/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10435 10436 question first answered 22/01/2024 17:29:15 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1609 label Biography information for Chloe Smith

1683469

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: International Cooperation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with international counterparts on their approach to the less survivable cancers.
tabling member constituency	Norwich North
tabling member printed	Chloe Smith
uin	10435
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>Cancer is being diagnosed at earlier stages, more often, with survival rates improving across almost all types of cancer with the National Health Service seeing and treating record numbers of cancer patients over the last two years.</p><p>The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients, including those less survivable cancers. We have already acted upon some of the areas that the 2020 Less Survivable Cancer Taskforce report requested, for example the introduction of targeted lung health checks, trials for cytosponge, and the roll out of non-specific symptom pathways. The report is available at the following link:</p><p><a href="https://lesssurvivablecancers.org.uk/our-asks/" target="_blank">https://lesssurvivablecancers.org.uk/our-asks/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10434 10436 question first answered 22/01/2024 17:29:15 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1609 label Biography information for Chloe Smith

1683471

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she plans to take to tackle less survivable cancers in the Major Conditions Strategy.
tabling member constituency	Norwich North
tabling member printed	Chloe Smith
uin	10436
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>Cancer is being diagnosed at earlier stages, more often, with survival rates improving across almost all types of cancer with the National Health Service seeing and treating record numbers of cancer patients over the last two years.</p><p>The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients, including those less survivable cancers. We have already acted upon some of the areas that the 2020 Less Survivable Cancer Taskforce report requested, for example the introduction of targeted lung health checks, trials for cytosponge, and the roll out of non-specific symptom pathways. The report is available at the following link:</p><p><a href="https://lesssurvivablecancers.org.uk/our-asks/" target="_blank">https://lesssurvivablecancers.org.uk/our-asks/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10434 10435 question first answered 22/01/2024 17:29:15 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1609 label Biography information for Chloe Smith

1683472

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Community Diagnostic Centres: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the rollout of community diagnostic centres on the time taken to diagnose less survivable cancers.
tabling member constituency	Norwich North
tabling member printed	Chloe Smith
uin	10437
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>The Government is taking steps through NHS England to improve outcomes for cancer patients, including those cancers mentioned by the Less Survivable Cancer Taskforce, namely lung, liver, brain, oesophageal, pancreatic and stomach. Diagnostic checks are a key part of cancer pathways and the 150 community diagnostic centres (CDCs) opened by the Government will give earlier diagnostic tests, benefitting millions of patients including those who are referred with suspected less survivable cancers. National Health Service systems have been asked to prioritise CDC capacity towards their most challenged cancer pathways, where this is clinically appropriate, and these centres have delivered over six million additional tests for all elective activity since July 2021. The CDC programme is on track to meet its target to open up to 160 CDCs by March 2025, with many due to open ahead of schedule.</p><p>In November 2022, the NHS also announced an expansion of direct access to diagnostic scans across all general practices, to help cut waiting times and speeding up cancer diagnosis, or all-clear for patients. The NHS is now looking to widen the clinical pathways for which this is offered.</p><p>Making improvements across different cancer types is critical to helping achieve the NHS Long Term Plan ambition of diagnosing 75% of patients at an early stage by 2028 and reducing inequalities in cancer survival. NHS England has commissioned new cancer clinical audits covering six cancer types, some of which are less survivable: pancreatic cancer, ovarian cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. All six audits will cover care delivered in England and Wales.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/01/2024 11:41:28 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1609 label Biography information for Chloe Smith

1683493

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anaesthesia Associates and Physician Associates: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with her counterpart in the Welsh government on the regulation of (a) physician associates and (b) anaesthesia associates.
tabling member constituency	Carmarthen East and Dinefwr
tabling member printed	Jonathan Edwards
uin	10443
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Ministers have corresponded with their counterparts in the Welsh Government, alongside those in Scotland and Northern Ireland, in taking forward the work to bring physician associates (PAs) and anaesthesia associates (AAs) into regulation.</p><p>The regulation of PAs and AAs has been subject to extensive public consultation over several years. Throughout the project, officials have engaged thoroughly with stakeholders including the regulators, the devolved administrations, the Professional Standards Authority for Health and Social Care, representative bodies, and service users in developing the policy behind this legislation.</p><p>This engagement has been crucial in shaping both our policy intention and the resultant legislation, to ensure that it remains a practical piece of legislation for the benefit of patient safety and registrants.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:15:38 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3943 label Biography information for Jonathan Edwards

1683497

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to increase the number of people living with diabetes who receive their NICE recommended care processes.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	10448
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Recovery of routine diabetes care following the pandemic is a key priority for the NHS England Diabetes Programme. Transformation funding between 2020/21 and 2022/23 has supported recovery, as such that rates of routine care delivery are now almost back to the pre-pandemic level. Services in the National Health Service are asked to continue this upward trajectory, with a particular focus on ensuring that people from socio-economically deprived areas receive their annual reviews.</p><p> </p><p>According to the report from the fourth quarter of 2022/23, the percentage of people who received all eight National Institute of Health and Care Excellence recommended care processes in England between January 2022 and March 2023 was 40.5% for type 1 diabetes and 57.8% for type 2/other diabetes, 15.3% and 20.6% higher respectively than the same period in the previous year. The percentages remained slightly lower than prior to the COVID-19 pandemic, where in the fourth quarter of 2019/20, they were 42.3% and 58.5%, respectively.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:16:33 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3973 label Biography information for Grahame Morris

1683514

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of pancreatic cancers were diagnosed at an early stage in the most recent year for which information is available.
tabling member constituency	Birmingham, Erdington
tabling member printed	Mrs Paulette Hamilton
uin	10572
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Latest figures from NHS Digital for cancers diagnosed between January and December 2021 show that 25% of pancreatic cancers were diagnosed at Stage 1 and 2.</p><p>NHS England is developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. There are now 113 of these pathways live, which are seeing more than 5,500 patients per month.</p><p>NHS England is also providing a route into pancreatic cancer surveillance for those at high-risk due to family history or at-risk genetic mutations and have formed an expert group to consider a pathway for Hepato-Pancreato-Biliary cancers, including pancreatic cancer.</p><p>NHS England is funding a new audit into pancreatic cancer to increase the consistency of access to treatments and to stimulate improvements in cancer treatment and outcomes for patients. The Royal College of Surgeons began work on this audit in October 2022 and the first report is expected in October 2024. In addition to this, the Getting it Right First-Time team in NHS England is undertaking a deep dive into pancreatic cancer, which will highlight actions National Health Service providers need to take to improve services, as well as gathering examples of good practice to share.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10573 question first answered 23/01/2024 09:18:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4938 label Biography information for Mrs Paulette Hamilton